Acute Effects of Herbal Dietary Supplements on Aerobic Performance

August 7, 2025 updated by: Nezire İnce, Eastern Mediterranean University

An Assessment of the Acute Effects of Herbal Dietary Supplements on Aerobic Performance in Recreational Athletes

Positive effects of herbal supplements such as red berries, ginseng, ashwagandha on athletic performance have been reported. The aim of this study was to evaluate the acute effects of a herbal dietary supplement prepared from a mixture of red berries, ginseng and ashwagandha on aerobic performance of recreational athletes.

Study Overview

Status

Completed

Conditions

Detailed Description

In the beginning of the study anthropometric measurements (weight (kg), height (cm), BMI, waist circumference (cm), body fat percentage, lean body mass, skeletal muscle mass) will be taken from the participants who accepted to participate in the study.

During the study, participants will be restricted from consuming alcohol, caffeine, red fruit, ginseng and ashwagandha.

First, Yoyo Intermittent Recovery Level 1 performance test (The Yo-Yo test is a maximal aerobic endurance fitness test, involving running between markers placed 20 meters apart, at increasing speeds, until exhaustion) will be done to all participants In this step, participants will not drink anything. Then there will be a 2-week break.

At the end of the 3-week break, the participants will be divided into two groups by block randomization method and one group will receive a herbal nutritional supplement mixture (100 ml 30 minutes before training). The other group will drink a placebo prepared with the same texture and consistency as our main mixture, containing an equal amount of carbohydrates (100 ml 30 minutes before training). Then the same performance test will be repeated. At the end of the test also 1 and 2 minutes after end of the test, the participants' heart rate measurement will be taken with a finger-type pulse oximeter and recorded . At the end of the test, perceived exertion levels will be questioned using the Borg scale.

Study Type

Interventional

Enrollment (Actual)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Famagusta, Cyprus, 99520
        • Nezire

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Being a student in the Exercise and Sports sciences department
  • Not using any supplement
  • Not being in a period that will affect sleep patterns (midterm/finals week, holiday, etc.)
  • Doing regular exercise

Exclusion Criteria:

  • Having a known food allergy
  • Using any supplement
  • Being a professional athlete
  • Drinking alcohol regularly

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control Group
Placebo will be given to this group (100ml, contain same carbohydrate amount as herbal supplement)
Active Comparator: Interventional Group
Herbal Supplement will be given to this group (100ml, Herbal Supplement)
Herbal supplement will be the mixture of strawberry, black mulberry, blueberry, raspberry, ginseng, ashwagandha, honey, water

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Vo2 Max
Time Frame: Up to 1 week
Once the test is completed, participants' Vo2 max values will be calculated using the formula "Vo2 max= Distance covered x 0.0084 + 36.4"
Up to 1 week
Total distance covered in Yo-Yo intermittent recovery test (level 1)
Time Frame: Up to 1 week
Once the test is completed, total distance covered by participants during the test will be recorded in meters.
Up to 1 week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change between end-test heart rate and heart rate 1 minute post Yo-Yo intermittent recovery test (level 1)
Time Frame: 1 minutes
Volunteers' heart rate was taken immediately after the Yo-Yo intermittent recovery test (level 1) and 1 minute post test. Heart rates were detected by using finger tip pulse oximeter
1 minutes
Change between end-test heart rate and heart rate 2 minutes post Yo-Yo intermittent recovery test (level 1)
Time Frame: 2 minutes
Volunteers' heart rate was taken immediately after the Yo-Yo intermittent recovery test (level 1) and 2 minute post test. Heart rates were detected by using finger tip pulse oximeter
2 minutes

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
BMI
Time Frame: Up to 2 weeks
BMI will be calculated. For the calculation of BMI; weight (kg), height (m) will be measured and formulated as follow (weight (kg) / (height (m))2
Up to 2 weeks
Waist Circumference
Time Frame: Up to 2 weeks
Waist circumference of the participants will be measured by placing the measuring tape around your middle at a point halfway between the bottom of your ribs and the top of your hips (just above the belly button) and recorded
Up to 2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Nezire Ince, Eastern Mediterranean University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 30, 2023

Primary Completion (Actual)

January 19, 2024

Study Completion (Actual)

October 30, 2024

Study Registration Dates

First Submitted

November 29, 2023

First Submitted That Met QC Criteria

December 25, 2023

First Posted (Actual)

December 28, 2023

Study Record Updates

Last Update Posted (Actual)

August 8, 2025

Last Update Submitted That Met QC Criteria

August 7, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • ETK00-2023-0207

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diet, Healthy

Clinical Trials on Herbal Supplement

Subscribe